XERS
Xeris Pharmaceuticals Inc
NASDAQ: XERS · HEALTHCARE · BIOTECHNOLOGY
$6.02
-1.15% today
Updated 2026-04-29
Market cap
$1.04B
P/E ratio
0.00
P/S ratio
3.56x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$4 – $10
Volume
1.9M
Xeris Pharmaceuticals Inc (XERS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07M | $1.56M | $2.46M | $2.72M | $2.72M | $49.59M | $110.25M | $163.91M | $203.07M | $291.85M |
| Revenue growth (YoY) | — | +44.7% | +58.4% | +10.4% | +0.0% | +1721.8% | +122.3% | +48.7% | +23.9% | +43.7% |
| Cost of revenue | $8000.00 | $4000.00 | $42000.00 | $1.60M | $1.60M | $13.32M | $22.63M | $28.64M | $36.83M | $53.41M |
| Gross profit | $1.07M | $1.55M | $2.42M | $1.12M | $1.12M | $36.27M | $87.61M | $135.27M | $166.24M | $238.43M |
| Gross margin | 99.3% | 99.7% | 98.3% | 41.1% | 41.1% | 73.1% | 79.5% | 82.5% | 81.9% | 81.7% |
| R&D | $10.24M | $20.17M | $40.65M | $60.44M | $60.44M | $25.16M | $20.97M | $22.34M | $25.56M | $31.16M |
| SG&A | $4.06M | $8.02M | $21.11M | $63.06M | $73.73M | $125.72M | $137.75M | $146.09M | $163.48M | $182.37M |
| Operating income | $-13.23M | $-26.63M | $-59.34M | $-122.38M | $-122.38M | $-115.16M | $-81.94M | $-44.01M | $-33.65M | $24.90M |
| Operating margin | -1230.8% | -1711.4% | -2407.5% | -4496.0% | -4496.0% | -232.2% | -74.3% | -26.8% | -16.6% | 8.5% |
| EBITDA | $-13.09M | $-26.38M | $-57.22M | $-119.57M | $-117.80M | $-113.67M | $-69.31M | $-23.73M | $-13.99M | $12.71M |
| EBITDA margin | -1217.8% | -1695.2% | -2321.1% | -4392.6% | -4327.6% | -229.2% | -62.9% | -14.5% | -6.9% | 4.4% |
| EBIT | $-13.21M | $-26.55M | $-57.53M | $-122.38M | $-118.88M | $-115.55M | $-81.98M | $-36.90M | $-26.62M | $554000.00 |
| Interest expense | $2000.00 | $2000.00 | $2.54M | $7.16M | $7.16M | $7.18M | $14.10M | $26.61M | $33.17M | $29.08M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.21M | $-26.55M | $-60.08M | $-125.58M | $-125.58M | $-122.72M | $-94.66M | $-62.26M | $-54.84M | $554000.00 |
| Net income growth (YoY) | — | -101.0% | -126.3% | -109.0% | +0.0% | +2.3% | +22.9% | +34.2% | +11.9% | +101.0% |
| Profit margin | -1228.7% | -1706.6% | -2437.3% | -4613.5% | -4613.5% | -247.5% | -85.9% | -38.0% | -27.0% | 0.2% |